94 related articles for article (PubMed ID: 29714078)
1. Overexpression of p21-activated kinase 2 is correlated with high-grade oral squamous cell carcinomas.
Xiao Y; Deng WW; Yang LL; Li H; Yu GT; Zhang WF; Sun ZJ
Future Oncol; 2018 May; 14(11):1091-1100. PubMed ID: 29714078
[TBL] [Abstract][Full Text] [Related]
2. Role of PFKFB3 and CD163 in Oral Squamous Cell Carcinoma Angiogenesis.
Li JJ; Mao XH; Tian T; Wang WM; Su T; Jiang CH; Hu CY
Curr Med Sci; 2019 Jun; 39(3):410-414. PubMed ID: 31209811
[TBL] [Abstract][Full Text] [Related]
3. Expression of myeloid zinc finger 1 and the correlation to clinical aspects of oral squamous cell carcinoma.
Ko CP; Yang LC; Chen CJ; Yeh KT; Lin SH; Yang SF; Chen MK; Lin CW
Tumour Biol; 2015 Sep; 36(9):7099-105. PubMed ID: 25877752
[TBL] [Abstract][Full Text] [Related]
4. Tumor-associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinoma.
Hu Y; He MY; Zhu LF; Yang CC; Zhou ML; Wang Q; Zhang W; Zheng YY; Wang DM; Xu ZQ; Wu YN; Liu LK
J Exp Clin Cancer Res; 2016 Jan; 35():12. PubMed ID: 26769084
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical Expression of CD105 and TGF-β1 in Oral Squamous Cell Carcinoma and Adjacent Apparently Normal Oral Mucosa and its Correlation With Clinicopathologic Features.
Nair S; Nayak R; Bhat K; Kotrashetti VS; Babji D
Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):35-41. PubMed ID: 25710582
[TBL] [Abstract][Full Text] [Related]
6. CD163+ tumor-associated macrophages correlated with poor prognosis and cancer stem cells in oral squamous cell carcinoma.
He KF; Zhang L; Huang CF; Ma SR; Wang YF; Wang WM; Zhao ZL; Liu B; Zhao YF; Zhang WF; Sun ZJ
Biomed Res Int; 2014; 2014():838632. PubMed ID: 24883329
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated fibroblasts and CD163-positive macrophages in oral squamous cell carcinoma: their clinicopathological and prognostic significance.
Fujii N; Shomori K; Shiomi T; Nakabayashi M; Takeda C; Ryoke K; Ito H
J Oral Pathol Med; 2012 Jul; 41(6):444-51. PubMed ID: 22296275
[TBL] [Abstract][Full Text] [Related]
8. End Binding 1 (EB1) overexpression in oral lesions and cancer: A biomarker of tumor progression and poor prognosis.
Kumar M; Mehra S; Thakar A; Shukla NK; Roychoudhary A; Sharma MC; Ralhan R; Chauhan SS
Clin Chim Acta; 2016 Aug; 459():45-52. PubMed ID: 27208742
[TBL] [Abstract][Full Text] [Related]
9. High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas.
Kidani K; Osaki M; Tamura T; Yamaga K; Shomori K; Ryoke K; Ito H
Oral Oncol; 2009 Jan; 45(1):39-46. PubMed ID: 18619895
[TBL] [Abstract][Full Text] [Related]
10. Expression of p53 and p21CIP1/WAF1 proteins in oral epithelial dysplasias and squamous cell carcinomas.
Kudo Y; Takata T; Ogawa I; Sato S; Nikai H
Oncol Rep; 1999; 6(3):539-45. PubMed ID: 10203588
[TBL] [Abstract][Full Text] [Related]
11. Low miR-143/miR-145 Cluster Levels Induce Activin A Overexpression in Oral Squamous Cell Carcinomas, Which Contributes to Poor Prognosis.
Bufalino A; Cervigne NK; de Oliveira CE; Fonseca FP; Rodrigues PC; Macedo CC; Sobral LM; Miguel MC; Lopes MA; Paes Leme AF; Lambert DW; Salo TA; Kowalski LP; Graner E; Coletta RD
PLoS One; 2015; 10(8):e0136599. PubMed ID: 26317418
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
[No Abstract] [Full Text] [Related]
13. Expression of AKR1B10 as an independent marker for poor prognosis in human oral squamous cell carcinoma.
Ko HH; Cheng SL; Lee JJ; Chen HM; Kuo MY; Cheng SJ
Head Neck; 2017 Jul; 39(7):1327-1332. PubMed ID: 28301069
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase IX overexpression regulates the migration and progression in oral squamous cell carcinoma.
Yang JS; Lin CW; Chuang CY; Su SC; Lin SH; Yang SF
Tumour Biol; 2015 Dec; 36(12):9517-24. PubMed ID: 26130414
[TBL] [Abstract][Full Text] [Related]
15. Repression of G protein-coupled receptor family C group 5 member A is associated with pathologic differentiation grade of oral squamous cell carcinoma.
Liu SL; Zhong SS; Ye DX; Chen WT; Zhang ZY; Deng J
J Oral Pathol Med; 2013 Nov; 42(10):761-8. PubMed ID: 23651229
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
17. Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression.
Vigneswaran N; Baucum DC; Wu J; Lou Y; Bouquot J; Muller S; Zacharias W
BMC Cancer; 2007 Jun; 7():108. PubMed ID: 17592646
[TBL] [Abstract][Full Text] [Related]
18. Macrophages and endothelial cells orchestrate tumor-associated angiogenesis in oral cancer via hedgehog pathway activation.
Valverde Lde F; Pereira Tde A; Dias RB; Guimarães VS; Ramos EA; Santos JN; Gurgel Rocha CA
Tumour Biol; 2016 Jul; 37(7):9233-41. PubMed ID: 26768620
[TBL] [Abstract][Full Text] [Related]
19. LAIR-1 overexpression and correlation with advanced pathological grade and immune suppressive status in oral squamous cell carcinoma.
Yang LL; Zhang MJ; Wu L; Mao L; Chen L; Yu GT; Deng WW; Zhang WF; Liu B; Sun WK; Sun ZJ
Head Neck; 2019 Apr; 41(4):1080-1086. PubMed ID: 30549148
[TBL] [Abstract][Full Text] [Related]
20. Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma.
Begum A; Imoto I; Kozaki K; Tsuda H; Suzuki E; Amagasa T; Inazawa J
Cancer Sci; 2009 Oct; 100(10):1908-16. PubMed ID: 19594544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]